- Home
- PRE vs CNTX Comparison
PRE vs CNTX Comparison
Compare PRE & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRE
- CNTX
- Stock Information
- Founded
- PRE 2014
- CNTX 2015
- Country
- PRE Hong Kong
- CNTX United States
- Employees
- PRE N/A
- CNTX 9
- Industry
- PRE Biotechnology: Laboratory Analytical Instruments
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- PRE Industrials
- CNTX Health Care
- Exchange
- PRE Nasdaq
- CNTX Nasdaq
- Market Cap
- PRE 131.3M
- CNTX 102.9M
- IPO Year
- PRE N/A
- CNTX 2021
- Fundamental
- Price
- PRE $12.32
- CNTX $1.11
- Analyst Decision
- PRE Buy
- CNTX Strong Buy
- Analyst Count
- PRE 1
- CNTX 7
- Target Price
- PRE $32.00
- CNTX $5.40
- AVG Volume (30 Days)
- PRE 193.4K
- CNTX 440.2K
- Earning Date
- PRE 11-10-2025
- CNTX 11-05-2025
- Dividend Yield
- PRE N/A
- CNTX N/A
- EPS Growth
- PRE N/A
- CNTX N/A
- EPS
- PRE N/A
- CNTX N/A
- Revenue
- PRE $57,051,000.00
- CNTX N/A
- Revenue This Year
- PRE $202.46
- CNTX N/A
- Revenue Next Year
- PRE $103.60
- CNTX N/A
- P/E Ratio
- PRE N/A
- CNTX N/A
- Revenue Growth
- PRE 256.82
- CNTX N/A
- 52 Week Low
- PRE $3.10
- CNTX $0.49
- 52 Week High
- PRE $17.99
- CNTX $2.25
- Technical
- Relative Strength Index (RSI)
- PRE 44.20
- CNTX 46.80
- Support Level
- PRE $12.05
- CNTX $1.04
- Resistance Level
- PRE $13.89
- CNTX $1.15
- Average True Range (ATR)
- PRE 1.42
- CNTX 0.09
- MACD
- PRE -0.47
- CNTX -0.03
- Stochastic Oscillator
- PRE 11.91
- CNTX 19.70
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.